Improving the outcome for children with cancer: Development of targeted new agents
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving the outcome for children with cancer: Development of targeted new agents
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 65, Issue 3, Pages 212-220
Publisher
American Cancer Society
Online
2015-03-09
DOI
10.3322/caac.21273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
- (2015) Kathryn G. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
- (2014) P. Schlegel et al. HAEMATOLOGICA
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
- (2014) K R Schultz et al. LEUKEMIA
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study
- (2014) Maryam Fouladi et al. PEDIATRIC BLOOD & CANCER
- Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group
- (2014) Lars M. Wagner et al. PEDIATRIC BLOOD & CANCER
- The 2010 Institute of Medicine Consensus Statement “A National Clinical Trials Network for the 21st Century”: Progress and Challenges
- (2014) John Mendelsohn et al. SEMINARS IN ONCOLOGY
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
- (2013) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- New drugs for children and adolescents with cancer: the need for novel development pathways
- (2013) Gilles Vassal et al. LANCET ONCOLOGY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unintended Consequences of Regulatory Initiatives in Childhood Cancer Drug Development
- (2013) Peter C. Adamson JAMA Pediatrics
- Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
- (2012) M. L. Loh et al. BLOOD
- A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report
- (2012) B. C. Widemann et al. CLINICAL CANCER RESEARCH
- Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?
- (2012) Andrea Gombos et al. INVESTIGATIONAL NEW DRUGS
- Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia
- (2012) Stephen P. Hunger et al. PEDIATRIC BLOOD & CANCER
- Children's Oncology Group's 2013 blueprint for research: Adolescent and young adult oncology
- (2012) David R. Freyer et al. PEDIATRIC BLOOD & CANCER
- Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups
- (2011) A. T. Schroen et al. CLINICAL CANCER RESEARCH
- Three years of paediatric regulation in the European Union
- (2011) Thorsten M. Olski et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
- (2011) Sheri L. Spunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: A report from the Children's Oncology Group
- (2011) Martin A. Champagne et al. PEDIATRIC BLOOD & CANCER
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
- (2010) R. C. Harvey et al. BLOOD
- Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors
- (2010) R. Bagatell et al. CLINICAL CANCER RESEARCH
- Funding of US Biomedical Research, 2003-2008
- (2010) E. Ray Dorsey JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2010) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors
- (2010) Elizabeth Fox et al. JOURNAL OF CLINICAL ONCOLOGY
- Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
- (2010) B. Geoerger et al. NEURO-ONCOLOGY
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- Sorafenib and Sunitinib
- (2009) A. Kim et al. ONCOLOGIST
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Characterization of the Pediatric Preclinical Testing Panel
- (2008) G. Neale et al. CLINICAL CANCER RESEARCH
- Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study
- (2008) Regina I. Jakacki et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
- (2008) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors
- (2008) Mark W. Kieran et al. PEDIATRIC BLOOD & CANCER
- Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group
- (2008) Maura O'Leary et al. SEMINARS IN ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now